JNM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


The Journal of Nuclear Medicine Vol. 41 No. 10 1727-1736
© 2000 by Society of Nuclear Medicine
This Article
Right arrow Abstract Freely available
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by DeGrado, T. R.
Right arrow Articles by Rockey, D. C.
Right arrow Search for Related Content
PubMed
Right arrow Articles by DeGrado, T. R.
Right arrow Articles by Rockey, D. C.

Preliminary Evaluation of 15-[18F]Fluoro-3-oxa-pentadecanoate as a PET Tracer of Hepatic Fatty Acid Oxidation

Timothy R. DeGrado, Shuyan Wang and Donald C. Rockey

Departments of Radiology and Medicine, Duke University Medical Center, Durham, North Carolina


Figure 1
View larger version (15K):
[in this window]
[in a new window]

 
FIGURE 1. Chemical structures of 18F-labeled fatty acids.

 

Figure 2
View larger version (10K):
[in this window]
[in a new window]

 
FIGURE 2. Two-compartment model for fitting FOP kinetics in isolated rat liver. Cp is radioactivity concentration in input perfusate; C1 and C2 represent first and second tissue compartments, respectively; and k1–k4 are rate constants.

 

Figure 3
View larger version (15K):
[in this window]
[in a new window]

 
FIGURE 3. Tissue-to-blood 18F radioactivity concentration ratios for FOP in healthy living rats. Each data point represents mean and SD for group of 3–4 rats killed at given time.

 

Figure 4
View larger version (20K):
[in this window]
[in a new window]

 
FIGURE 4. Reverse-phase HPLC analysis of FOP standard (A) and 18F radioactivity in representative samples of serum taken from control or etomoxir-treated rats 15 min after injection of FOP (B and C). Small levels of unidentified polar metabolites of FOP were observed in serum samples. Intact FOP composed 85.4% ± 1.4% and 96.7% ± 0.8% (P < 0.0001) of total radioactivity in serum 15 min after injection for control and etomoxir-treated rats, respectively.

 

Figure 5
View larger version (14K):
[in this window]
[in a new window]

 
FIGURE 5. Characteristic time–activity curves for FOP in isolated rat livers. Livers were perfused in normoxic (95% O2) or hypoxic (15% O2) conditions. Livers were pulse perfused with radiotracer in perfusate at constant concentration over the interval 0–20 min, followed by 20-min washout.

 

Figure 6
View larger version (17K):
[in this window]
[in a new window]

 
FIGURE 6. Two-compartment model fit to 18F radioactivity kinetics in normoxic isolated rat liver administered FOP as 20-min pulse followed by 20-min washout. Measured kinetics were successfully fit by model, showing no significant discrepancies between data and model curves besides statistical counting noise. k1–k4 are rate constants.

 

Figure 7
View larger version (17K):
[in this window]
[in a new window]

 
FIGURE 7. Relationship of estimates of DVs of FOP to FPOR in isolated rat liver. Each experiment is represented by single data point on each graph. Both normoxic (95% O2) data (•) and hypoxic (15% O2) data ({blacktriangleup}) are shown.

 





HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
JOURNAL OF NUCLEAR MEDICINE TECHNOLOGY THE JOURNAL OF NUCLEAR MEDICINE
Copyright © 2000 by the Society of Nuclear Medicine.